BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/13/2025 6:51:08 AM | Browse: 54 | Download: 287
 |
Received |
|
2025-07-25 14:36 |
|
Peer-Review Started |
|
2025-07-25 14:36 |
|
First Decision by Editorial Office Director |
|
2025-08-07 09:44 |
|
Return for Revision |
|
2025-08-07 09:44 |
|
Revised |
|
2025-08-18 14:10 |
|
Publication Fee Transferred |
|
2025-08-21 01:49 |
|
Second Decision by Editor |
|
2025-10-13 02:50 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-13 06:40 |
|
Articles in Press |
|
2025-10-13 06:40 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-10-30 09:35 |
|
Publish the Manuscript Online |
|
2025-11-13 06:51 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Development and validation of a predictive model for portal-systemic venous invasion grading in borderline resectable pancreatic cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Fang-Fei Wang, Xiao-Di Dai, Xin Zhao, Qiang He and Shao-Cheng Lyu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shao-Cheng Lyu, Department of Hepatobiliary Pancreas and Spleen Surgery, Beijing Chao-Yang Hospital, Capital Medical University, No. 8 Gongtinan Road, Chaoyang District, Beijing 100020, China. shaocheng0502@163.com |
| Key Words |
Borderline resectable pancreatic cancer; Portosystemic venous invasion; Pathological grading; Predictive model; Adventitial invasion; Muscularis propria invasion; Intimal invasion |
| Core Tip |
This study developed a predictive model for pathological grading of portosystemic venous invasion depth in borderline resectable pancreatic cancer using routine preoperative indicators: Serum carbohydrate antigen 19-9, computed tomography circumferential involvement angle, and luminal compromise. The model achieved high accuracy (C-index 0.928) in stratifying venous invasion depth into adventitial, muscularis propria, or intimal invasion, which significantly affected prognosis (e.g., intimal invasion showed worst median overall survival of 9 months). This innovative tool enables preoperative risk quantification, guiding personalized therapy decisions such as neoadjuvant intensification or surgical planning, and addresses a critical unmet need in precision oncology for borderline resectable pancreatic cancer. |
| Publish Date |
2025-11-13 06:51 |
| Citation |
Wang FF, Dai XD, Zhao X, He Q, Lyu SC. Development and validation of a predictive model for portal-systemic venous invasion grading in borderline resectable pancreatic cancer. World J Gastroenterol 2025; 31(42): 112354 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i42/112354.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i42.112354 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
